Abstract:The Hippo pathway plays a critical role in organ size control in development. Deregulation of the Hippo pathway leads to drastic enlargement of organs due to increased cell proliferation, inhibition of apoptosis, and dedifferentiation of differentiated cells. Interestingly, deregulation of the Hippo pathway also plays a critical role in tumorigenesis. However, precise roles of the Hippo pathway in tumorigenesis are unclear. By generating genetically defined liver tumor-initiating cells (TICs) with Hippo pathway inactivation or YAP activation, we found that the Hippo pathway unexpectedly mediates a crosstalk between TICs and the immune system. Via cytokines induced by YAP, TICs actively recruit M2 macrophages from as early as the single-cell stage. Elimination of TIC-associated macrophages (TICAMs) abolishes tumorigenesis in a manner dependent on the immune system. Furthermore, YAP activation has been observed in TICs induced by pathologically relevant oncogenes in murine livers and in human hepatocellular carcinoma (HCC) precancerous lesions. These results demonstrate for the first time that macrophages play a decisive role in the survival of single TIC in vivo and provide a proof of principle for TIC elimination by targeting YAP or M2 macrophages. Furthermore, we found that YAP induces leukocyte-specific integrin β2 (ITGB2) expression in cancer cells, thereby promoting cell invasion through the endothelium in a manner mimicking leukocytes. Through independent biochemical purification and a functional screen, we further identified PR/SET domain 4 (PRDM4) as a transcription factor interacting with the WW domains of YAP to mediate ITGB2 expression and cell invasion. Consistently, ITGB2 and PRDM4 mRNA levels are significantly increased in metastatic prostate cancer. In addition, PRDM4 contributes to YAP-induced tumorigenesis, possibly via mediating the expression of other YAP target genes. Our results demonstrate that YAP promotes cell invasion by inducing leukocyte-specific integrin expression and identify PRDM4 as a novel transcription factor for YAP targets. Citation Format: Xiaocan Guo, Huan Liu, Xiaolei Cao, Bin Zhao. The Hippo pathway in cancer [abstract]. In: Proceedings of the AACR Special Conference on the Hippo Pathway: Signaling, Cancer, and Beyond; 2019 May 8-11; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2020;18(8_Suppl):Abstract nr IA21.

Heat stress activates YAP/TAZ to induce the heat shock transcriptome

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation

Molecular mechanisms of the mammalian Hippo signaling pathway.

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Mitochondrial stress activates YAP/TAZ through RhoA oxidation to promote liver injury

Abstract IA21: the Hippo Pathway in Cancer

TEAD Mediates YAP-dependent Gene Induction and Growth Control

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

Integration of Hippo Signalling and the Unfolded Protein Response to Restrain Liver Overgrowth and Tumorigenesis

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer

Hippo Signalling Governs Cytosolic Nucleic Acid Sensing Through Yap/Taz-Mediated Tbk1 Blockade

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

The Hippo pathway noncanonically drives autophagy and cell survival in response to energy stress

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

The LKB1–TSSK1B axis controls YAP phosphorylation to regulate the Hippo–YAP pathway